170 results on '"EELS - Earth"'
Search Results
2. Dose-dependent prebiotic effect of lactulose in a computer-controlled in vitro model of the human large intestine
- Subjects
MSB - Microbiology and Systems Biology ADME - ADME/DMPK ,Biomedical Innovation ,Butyrate ,Life Triskelion BV ,Environmental and Life Sciences TNO Bedrijven ,Lactulose ,EELS - Earth ,Bifidobacteria ,Ammonia ,Lactobacilli ,Microbial fermentation ,Anaerostipes ,Biology ,Healthy Living - Abstract
Lactulose, a disaccharide of galactose and fructose, used as a laxative or ammonia-lowering drug and as a functional food ingredient, enhances growth of Bifidobacterium and Lactobacillus at clinically relevant dosages. The prebiotic effect of subclinical dosages of Lactulose, however, remains to be elucidated. This study analyses changes in the microbiota and their metabolites after a 5 days Lactulose treatment using the TIM-2 system, a computer-controlled model of the proximal large intestine representing a complex, high density, metabolically active, anaerobic microbiota of human origin. Subclinical dosages of 2-5 g Lactulose were used. While 2 g Lactulose already increased the short-chain fatty acid levels of the intestinal content, 5 g Lactulose were required daily for 5 days in this study to exert the full beneficial prebiotic effect consisting of higher bacterial counts of Bifidobacterium, Lactobacillus, and Anaerostipes, a rise in acetate, butyrate and lactate, as well as a decrease in branched-chain fatty acids, pH (suggested by an increase in NaOH usage), and ammonia. © 2017 by the authors. Licensee MDPI, Basel, Switzerland.
- Published
- 2017
3. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis
- Subjects
Mouse ,Hypercholesterolemia ,Drug potentiation ,Biomedical Innovation ,Brown adipose tissue ,Triacylglycerol ,5 [2 [[2 (3 chlorophenyl) 2 hydroxyethyl]amino]propyl] 1 ,Animal tissue ,EELS - Earth ,Life ,Atorvastatin ,Cholesterol metabolism ,Lipid and lipoprotein metabolism ,Animal model ,cardiovascular diseases ,Animal experiment ,Western diet ,Lipoprotein ,Biology ,High density lipoprotein cholesterol ,Lipoprotein metabolism ,Lipid liver level ,Lipid composition ,nutritional and metabolic diseases ,Atherosclerosis ,Fatty acid ,Proprotein convertase 9 ,Lipid transport ,Nonhuman ,Environmental and Life Sciences ,Lipid oxidation ,Triacylglycerol blood level ,Drug effect ,2 dicarboxylic acid ,Cholesterol ,Cholesterol blood level ,Lipid metabolism ,3 benzodioxole 2 ,lipids (amino acids, peptides, and proteins) ,Energy expenditure ,Female ,Gene expression ,MHR - Metabolic Health Research ,Controlled study ,Healthy Living - Abstract
Background and aims Activation of brown adipose tissue (BAT) reduces both hyperlipidemia and atherosclerosis by increasing the uptake of triglyceride-derived fatty acids by BAT, accompanied by formation and clearance of lipoprotein remnants. We tested the hypothesis that the hepatic uptake of lipoprotein remnants generated by BAT activation would be accelerated by concomitant statin treatment, thereby further reducing hypercholesterolemia and atherosclerosis. Methods APOE*3-Leiden.CETP mice were fed a Western-type diet and treated without or with the selective β3-adrenergic receptor (AR) agonist CL316,243 that activates BAT, atorvastatin (statin) or both. Results β3-AR agonism increased energy expenditure as a result of an increased fat oxidation by activated BAT, which was not further enhanced by statin addition. Accordingly, statin treatment neither influenced the increased uptake of triglyceride-derived fatty acids from triglyceride-rich lipoprotein-like particles by BAT nor further lowered plasma triglyceride levels induced by β3-AR agonism. Statin treatment increased the hepatic uptake of the formed cholesterol-enriched remnants generated by β3-AR agonism. Consequently, statin treatment further lowered plasma cholesterol levels. Importantly, statin, in addition to β3-AR agonism, also further reduced the atherosclerotic lesion size as compared to β3-AR agonism alone, without altering lesion severity and composition. Conclusions Statin treatment accelerates the hepatic uptake of remnants generated by BAT activation, thereby increasing the lipid-lowering and anti-atherogenic effects of BAT activation in an additive fashion. We postulate that, in clinical practice, combining statin treatment with BAT activation is a promising new avenue to combat hyperlipidemia and cardiovascular disease.
- Published
- 2017
4. Spontaneous ultra-weak photon emission in correlation to inflammatory metabolism and oxidative stress in a mouse model of collagen-induced arthritis
- Subjects
Ultra-weak photon emission ,MSB - Microbiology and Systems Biology ,Life ,Collagen-induced arthritis ,Metabolomics ,Biomedical Innovation ,Correlation networks ,Systems biology ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
The increasing prevalence of rheumatoid arthritis has driven the development of new approaches and technologies for investigating the pathophysiology of this devastating, chronic disease. From the perspective of systems biology, combining comprehensive personal data such as metabolomics profiling with ultra-weak photon emission (UPE) data may provide key information regarding the complex pathophysiology underlying rheumatoid arthritis. In this article, we integrated UPE with metabolomics-based technologies in order to investigate collagen-induced arthritis, a mouse model of rheumatoid arthritis, at the systems level, and we investigated the biological underpinnings of the complex dataset. Using correlation networks, we found that elevated inflammatory and ROS-mediated plasma metabolites are strongly correlated with a systematic reduction in amine metabolites, which is linked to muscle wasting in rheumatoid arthritis. We also found that increased UPE intensity is strongly linked to metabolic processes (with correlation co-efficiency | r | value > 0.7), which may be associated with lipid oxidation that related to inflammatory and/or ROS-mediated processes. Together, these results indicate that UPE is correlated with metabolomics and may serve as a valuable tool for diagnosing chronic disease by integrating inflammatory signals at the systems level. Our correlation network analysis provides important and valuable information regarding the disease process from a system-wide perspective.
- Published
- 2017
5. TNO i-screen intestinal microbiota screening platform for determining metabolism of drugs
- Subjects
Metabolism ,MSB - Microbiology and Systems Biology ,Intestinal ,Life ,Drugs ,Biomedical Innovation ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth ,Absorption - Abstract
TNO’s intestinal screening model (TNO i-screen) helps to quickly identify pharmacological compounds that are metabolized by intestinal microbiota. For pharmaceutical companies, searching for novel pharmaceuticals is a complex and time-consuming process. When a novel drug has been selected, extensive in vitro and clinical studies are required to demonstrate its metabolism, safety and efficacy prior to releasing it to the market. Increasing evidence has shown that gut microbiota are involved in the metabolic transformation of many drugs, influencing drug pharmacokinetics and thus, efficacy and safety profiles.
- Published
- 2016
6. Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium
- Subjects
Life ,RAPID - Risk Analysis for Products in Development ,Biomedical Innovation ,Environmental and Life Sciences ,Biology ,Healthy Living ,Prolonged incubation ,EELS - Earth ,Precision-cut liver slices - Abstract
Precision-cut liver slices (PCLS) are an ex vivo model for metabolism and toxicity studies. However, data on the maintenance of the morphological integrity of the various cell types in the slices during prolonged incubation are lacking. Therefore, our aims were to characterize morphological and functional changes in rat PCLS during five days of incubation in a rich medium, RegeneMed®, and a standard medium, Williams' Medium E. Although cells of all types in the slices remain viable, profound changes in morphology were observed, which were more prominent in RegeneMed®. Slices underwent notable fibrosis, bile duct proliferation and fat deposition. Slice thickness increased, resulting in necrotic areas, while slice diameter decreased, possibly indicating cell migration. An increased proliferation of parenchymal and non-parenchymal cells (NPCs) was observed. Glycogen, albumin and Cyp3a1 were maintained albeit to a different level in two media. In conclusion, both hepatocytes and NPCs remain viable and functional, enabling five-day toxicity studies. Tissue remodeling and formation of a new capsule-like cell lining around the slices are evident after 3-4 days. The differences in effects between media emphasize the importance of media selection and of the recognition of morphological changes in PCLS, when interpreting results from toxicological or pharmacological studies. © 2015 Elsevier B.V.
- Published
- 2015
7. InTESTine™ study processes that determine intestinal absorption
- Subjects
Metabolism ,MSB - Microbiology and Systems Biology ,Intestinal ,Life ,Biomedical Innovation ,Environmental and Life Sciences ,Healthy Living ,EELS - Earth ,Absorption - Published
- 2015
8. Computational design of safer nanomaterials
- Subjects
Life ,RAPID - Risk Analysis for Products in Development ,Nanotechnology ,Biomedical Innovation ,Environmental and Life Sciences ,Healthy Living ,EELS - Earth - Abstract
Nanomaterials are expected to find applications in numerous consumer products, posing the challenge to guarantee their safety and environmental sustainability before they can be transferred from research labs to end-consumer products. One emerging solution, called safe design, relies on the implementation, throughout the R&D phase, of key aspects related to the safety and sustainability of nanomaterials, in this way anticipating potential negative health effects. This article proposes a computational screening approach to design safer nanomaterials. The work is based on the calculation of key physicochemical properties of nanomaterials that are related to their safety, functionality and synthetic feasibility. These properties are then used to select a pool of promising structures for further experimental testing and development. The concept is demonstrated on a set of core@shell metal oxide nanoparticles for transparent UV-protecting coating applications. This journal is © The Royal Society of Chemistry.
- Published
- 2015
9. The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps
- Subjects
Cell death ,Male ,Staphylococcus aureus ,Fluorescence microscopy cell ,Mouse ,Hydrophobicity ,Biomedical Innovation ,Immunofluorescence microscopy ,EELS - Earth ,Life ,Electron microscopy ,Nuclear membrane ,Beta defensin 1 ,Cell nucleus membrane ,Polymyxin B ,Bacterial membrane ,Neutrophil ,CBRN - CBRN Protection ,NETosis ,Cathelicidin ,Cathelicidin antimicrobial peptide LL 37 ,Extracellular matrix ,Nonhuman ,Environmental and Life Sciences ,1404-26-8 ,Normal human ,Phenotype ,Lamin B ,1405-20-5 ,Animal cell ,Neutrophil extracellular trap ,Controlled study ,Healthy Living - Abstract
NETs (neutrophil extracellular traps) have been described as a fundamental innate immune defence mechanism. Duringformation of NETs, the nuclear membrane is disrupted by an asyet unknown mechanism. In the present study we investigated the role of human cathelicidin LL-37 in nuclear membrane disruption and formation of NETs. Immunofluorescence microscopy revealed that 5 μMLL-37 significantly facilitated NET formation by primary human blood-derived neutrophils alone, in the presence of the classical chemical NET inducer PMA or in the presence of Staphylococcus aureus. Parallel assays with a random LL-37 fragment library indicated that the NET induction is mediated by the hydrophobic character of the peptide. The translocalization of LL-37 towards the nucleus and the disruption of the nuclear membrane were visualized using confocal fluorescence microscopy. In conclusion, the present study demonstrates a novel role for LL-37 in the formation of NETs.
- Published
- 2014
10. Feasibility of a 3D human airway epithelial model to study respiratory absorption
- Subjects
TARA - Toxicology and Risk Assessment PHS - Pharmacokinetics & Human Studies (tot 2013 daarna KFP) ,Respiratory absorption ,Biomedical Innovation ,3D human airway model ,Life Triskelion BV ,Environmental and Life Sciences TNO Bedrijven ,Biology ,Healthy Living ,EELS - Earth - Abstract
The respiratory route is an important portal for human exposure to a large variety of substances. Consequently, there is an urgent need for realistic in vitro strategies for evaluation of the absorption of airborne substances with regard to safety and efficacy assessment. The present study investigated feasibility of a 3D human airway epithelial model to study respiratory absorption, in particular to differentiate between low and high absorption of substances. Bronchial epithelial models (MucilAir™), cultured at the air–liquid interface, were exposed to eight radiolabeled model substances via the apical epithelial surface. Absorption was evaluated by measuring radioactivity in the apical compartment, the epithelial cells and the basolateral culture medium. Antipyrine, caffeine, naproxen and propranolol were highly transported across the epithelial cell layer (>5%), whereas atenolol, mannitol, PEG-400 and insulin were limitedly transported (
- Published
- 2014
11. Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice, a translational model for atherosclerosis
- Subjects
Mouse ,Monocyte chemotactic protein 1 ,Biomedical Innovation ,Animal tissue ,Cholesterol intake ,EELS - Earth ,Endothelial leukocyte adhesion molecule 1 ,Life ,Transgenic mouse ,Atorvastatin ,Animal model ,Animal experiment ,Biology ,Priority journal ,Atherosclerosis ,Nonhuman ,Environmental and Life Sciences ,Cholesterol blood level ,Very low density lipoprotein ,Alanine aminotransferase ,lipids (amino acids, peptides, and proteins) ,Female ,Apolipoprotein E ,Knee osteoarthritis ,Cholesterol ester transfer protein ,MHR - Metabolic Health Research ,Etimibe ,Controlled study ,Healthy Living ,Serum amyloid A - Abstract
Objective Hypercholesterolaemia, a risk factor for atherosclerosis (ATH), has been suggested to have a role in the development of osteoarthritis (OA). To test this hypothesis, the effect of cholesterol and different cholesterol-lowering treatments on OA was investigated in a mouse model resembling human lipoprotein metabolism. Methods Female ApolipoproteinE*3Leiden.human Cholesteryl Ester Transfer Protein mice received a westerntype diet with 0.1% (w/w) cholesterol (LC), 0.3% (w/w) cholesterol alone (HC) or treated with 3 mg/kg/day atorvastatin or 0.3 mg/kg/day ezetimibe. One group remained on chow (control). After 39 weeks, OA grades of the knees and the extent of ATH were determined. Plasma cholesterol levels were measured throughout the study. Results LC and HC groups developed significantly more OA at the medial side than the control group in a dosedependent manner. Atorvastatin but not ezetimibe treatment significantly suppressed OA development. As expected, features of ATH were significantly increased in the LC and HC groups compared with the control group and suppressed by atorvastatin (48%) and ezetimibe (55%) treatment. There were significant correlations between the development of OA on the medial side of the joint and cholesterol exposure (r=0.4) or ATH features (r=0.3). Conclusions Dietary cholesterol and accordingly increased plasma levels play a role in the development of OA. The correlation found between OA, cholesterol and ATH demonstrates that these variables are connected, but indicates the contribution of other ongoing processes in the development of OA. The suppressive effect on OA development of atorvastatin but not of ezetimibe, which had similar cholesterol exposure levels, corroborates these findings.
- Published
- 2014
12. Development of detection techniques for monitoring and optimizing biocide dosing in seawater flooding systems
- Subjects
Thiocholine ,Biomedical Innovation ,PHS - Pharmacokinetics & Human Studies RAPID - Risk Analysis for Products in Development ,Environmental and Life Sciences ,EELS - Earth ,Real-time detection ,Life ,Biocide residuals ,Acetylcholinesterase ,Seawater ,Biology ,Healthy Living ,Benzyl-dimethyldecylammonium ,Colorimetric - Abstract
Anaerobic microorganisms which are frequently associated with corrosion fail Control of bacterial activity are posing major challenge in Saudi Arabia's massive seawater flooding systems. Biocides are used to control bacteria throughout the oil industry. A study to explore the feasibility to develop a detection technique for biocide batch treatments, preferably on-line and in real time, for their potential use in seawater flooding system network is described. Several methods to measure key components of the biocide composition were investigated in the initial stage. Three different techniques were explored during the feasibility phase study to detect and measure concentrations of biocide in seawater. This helped our plans for designing a sensor based on such detection techniques. The techniques explored were to monitor change in temperature, change in pH, and change in chromophore concentration (colorimetric) in the enzymatic reaction. The investigated methods included the use of acetylcholine esterase, based on the pH change as a result of acetate formation, the production of reaction heat (thermal) or on the colorimetric detection of the chromophore concentration based on the conversion of acetylthiocholine in combination with a chromophore. It was found that the colorimetric system was the most versatile system to perform the measurement to be able to show the feasibility of the method in real sea water samples and to demonstrate the effects of the biocides on the measurement system.
- Published
- 2013
13. Profiling the Secretion of Soluble Mediators by End Stage Osteoarthritis Synovial Tissue Explants Reveals a Reduced Responsiveness to an Inflammatory Trigger
- Subjects
Life ,Biomedical Innovation ,MHR - Metabolic Health Research ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Objective:Evidence is accumulating that synovial tissue plays an active role in osteoarthritis (OA), however, exact understanding of its contribution is lacking. In order to further elucidate its role in the OA process, we aimed to identify the secretion pattern of soluble mediators by synovial tissue and to assess its ability to initiate cartilage degeneration.Methods:Synovial tissue explants (STEs) obtained from donors without history of OA (n = 8) or from end stage OA patients (n = 16) were cultured alone or together with bovine cartilage explants in the absence or presence of IL-1α. The secretion of 48 soluble mediators was measured and the effect on glycosaminoglycan (GAG) release and matrix metalloproteinase (MMP) activity was determined.Results:Normal and OA STEs secreted comparable levels of almost all measured soluble mediators. However, in the presence of IL-1α these mediators were less secreted by OA than by normal STEs of which 15 differed significantly (p
- Published
- 2013
14. Both Transient and Continuous Corticosterone Excess Inhibit Atherosclerotic Plaque Formation in APOE*3-Leiden.CETP Mice
- Subjects
Life ,Biomedical Innovation ,MHR - Metabolic Health Research ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Introduction: The role of glucocorticoids in atherosclerosis development is not clearly established. Human studies show a clear association between glucocorticoid excess and cardiovascular disease, whereas most animal models indicate an inhibitory effect of glucocorticoids on atherosclerosis development. These animal models, however, neither reflect long-term glucocorticoid overexposure nor display human-like lipoprotein metabolism. Aim: To investigate the effects of transient and continuous glucocorticoid excess on atherosclerosis development in a mouse model with human-like lipoprotein metabolism upon feeding a Western-type diet. Methods: Pair-housed female APOE*3-Leiden.CETP (E3L.CETP) mice fed a Western-type containing 0.1% cholesterol for 20 weeks were given corticosterone (50 μg/ml) for either 5 (transient group) or 17 weeks (continuous group), or vehicle (control group) in the drinking water. At the end of the study, atherosclerosis severity, lesion area in the aortic root, the number of monocytes adhering to the endothelial wall and macrophage content of the plaque were measured. Results: Corticosterone treatment increased body weight and food intake for the duration of the treatment and increased gonadal and subcutaneous white adipose tissue weight in transient group by +35% and +31%, and in the continuous group by +140% and 110%. Strikingly, both transient and continuous corticosterone treatment decreased total atherosclerotic lesion area by -39% without lowering plasma cholesterol levels. In addition, there was a decrease of -56% in macrophage content of the plaque with continuous corticosterone treatment, and a similar trend was present with the transient treatment. Conclusion: Increased corticosterone exposure in mice with human-like lipoprotein metabolism has beneficial, long-lasting effects on atherosclerosis, but negatively affects body fat distribution by promoting fat accumulation in the long-term. This indicates that the increased atherosclerosis observed in humans in states of glucocorticoid excess may not be related to cortisol per se, but might be the result of complex indirect effects of cortisol. © 2013 Auvinen et al.
- Published
- 2013
15. Use of nutrigenomics endpoints in dietary interventions
- Subjects
Nutrigenomics ,Life ,Nutrition intervention ,Biomedical Innovation ,Anti-inflammatory ,PHS - Pharmacokinetics & Human Studies ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth ,Challenge testing - Abstract
In this paper, the nutrigenomics approach is discussed as a research tool to study the physiological effects of nutrition and consequently how nutrition affects health and disease (endpoints). Nutrigenomics is the study of the effects of foods and food constituents on gene expression; the analyses include analysis of mRNA, proteins and metabolites. Nutrigenomics may be useful in dealing with the challenges that nutrition research is facing; by integrating the description of numerous active genes and metabolic pathways stronger evidence and new biomarkers for subtle nutritional effects may be obtained. Also, a new definition of disease and health may be needed. The use of tests challenging homoeostasis is being proposed to help define health. Challenge tests may be able to demonstrate in a better way subtle beneficial effects of nutrition on health. The paper describes some basic concepts relevant to nutrition research as well as some of the possibilities that are offered by nutrigenomics technology. Some of its applications are described. Copyright © The Author 2013.
- Published
- 2013
16. How do metabolites differ from their parent molecules and how are they excreted?
- Subjects
Life ,Biomedical Innovation ,QS - Quality & Safety ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Understanding which physicochemical properties, or property distributions, are favorable for successful design and development of drugs, nutritional supplements, cosmetics, and agrochemicals is of great importance. In this study we have analyzed molecules from three distinct chemical spaces (i) approved drugs, (ii) human metabolites, and (iii) traditional Chinese medicine (TCM) to investigate four aspects determining the disposition of small organic molecules. First, we examined the physicochemical properties of these three classes of molecules and identified characteristic features resulting from their distinctive biological functions. For example, human metabolites and TCM molecules can be larger and more hydrophobic than drugs, which makes them less likely to cross membranes. We then quantified the shifts in physicochemical property space induced by metabolism from a holistic perspective by analyzing a data set of several thousand experimentally observed metabolic trees. Results show how the metabolic system aims to retain nutrients/micronutrients while facilitating a rapid elimination of xenobiotics. In the third part we compared these global shifts with the contributions made by individual metabolic reactions. For better resolution, all reactions were classified into phase I and phase II biotransformations. Interestingly, not all metabolic reactions lead to more hydrophilic molecules. We were able to identify biotransformations leading to an increase of logP by more than one log unit, which could be used for the design of drugs with enhanced efficacy. The study closes with the analysis of the physicochemical properties of metabolites found in the bile, faeces, and urine. Metabolites in the bile can be large and are often negatively charged. Molecules with molecular weight >500 Da are rarely found in the urine, and most of these large molecules are charged phase II conjugates. © 2013 American Chemical Society.
- Published
- 2013
17. The role of coproporphyrinogen III oxidase and ferrochelatase genes in heme biosynthesis and regulation in Aspergillus niger
- Subjects
Aspergillus ,MSB - Microbiology and Systems Biology ,Life ,Heme biosynthesis ,Biomedical Innovation ,Environmental and Life Sciences ,Biology ,Healthy Living ,Coproporphyrinogen III oxidase ,Ferrochelatase ,EELS - Earth ,Peroxidase - Abstract
Heme is a suggested limiting factor in peroxidase production by Aspergillus spp., which are well-known suitable hosts for heterologous protein production. In this study, the role of genes coding for coproporphyrinogen III oxidase (hemF) and ferrochelatase (hemH) was analyzed by means of deletion and overexpression to obtain more insight in fungal heme biosynthesis and regulation. These enzymes represent steps in the heme biosynthetic pathway downstream of the siroheme branch and are suggested to play a role in regulation of the pathway. Based on genome mining, both enzymes deviate in cellular localization and protein domain structure from their Saccharomyces cerevisiae counterparts. The lethal phenotype of deletion of hemF or hemH could be remediated by heme supplementation confirming that Aspergillus niger is capable of hemin uptake. Nevertheless, both gene deletion mutants showed an extremely impaired growth even with hemin supplementation which could be slightly improved by media modifications and the use of hemoglobin as heme source. The hyphae of the mutant strains displayed pinkish coloration and red autofluorescence under UV indicative of cellular porphyrin accumulation. HPLC analysis confirmed accumulation of specific porphyrins, thereby confirming the function of the two proteins in heme biosynthesis. Overexpression of hemH, but not hemF or the aminolevulinic acid synthase encoding hemA, modestly increased the cellular heme content, which was apparently insufficient to increase activity of endogenous peroxidase and cytochrome P450 enzyme activities. Overexpression of all three genes increased the cellular accumulation of porphyrin intermediates suggesting regulatory mechanisms operating in the final steps of the fungal heme biosynthesis pathway. © 2013 Springer-Verlag Berlin Heidelberg.
- Published
- 2013
18. Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
- Subjects
Life ,nutritional and metabolic diseases ,Biomedical Innovation ,lipids (amino acids, peptides, and proteins) ,MHR - Metabolic Health Research ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Objective:Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely increases HDL-cholesterol. Despite evidence for an atheroprotective effect of niacin from previous small clinical studies, the large outcome trials, AIM-HIGH and HPS2-THRIVE did not reveal additional beneficial effects of niacin (alone or in combination with laropiprant) on top of statin treatment. We aimed to address this apparent discrepancy by investigating the effects of niacin without and with simvastatin on atherosclerosis development and determine the underlying mechanisms, in APOE*3Leiden.CETP mice, a model for familial dysbetalipoproteinemia (FD).Approach and Results:Mice were fed a western-type diet containing cholesterol without or with niacin (120 mg/kg/day), simvastatin (36 mg/kg/day) or their combination for 18 weeks. Similarly as in FD patients, niacin reduced total cholesterol by -39% and triglycerides by -50%, (both P
- Published
- 2013
19. Abiotic and Microbiotic Factors Controlling Biofilm Formation by Thermophilic Sporeformers
- Subjects
MSB - Microbiology and Systems Biology ,Life ,Biomedical Innovation ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
One of the major concerns in the production of dairy concentrates is the risk of contamination by heat-resistant spores from thermophilic bacteria. In order to acquire more insight in the composition of microbial communities occurring in the dairy concentrate industry, a bar-coded 16S amplicon sequencing analysis was carried out on milk, final products, and fouling samples taken from dairy concentrate production lines. The analysis of these samples revealed the presence of DNA from a broad range of bacterial taxa, including a majority of mesophiles and a minority of (thermophilic) sporeforming bacteria. Enrichments of fouling samples at 55°C showed the accumulation of predominantly Brevibacillus and Bacillus, whereas enrichments at 65°C led to the accumulation of Anoxybacillus and Geobacillus species. Bacterial population analysis of biofilms grown using fouling samples as an inoculum indicated that both Anoxybacillus and Geobacillus preferentially form biofilms on surfaces at air-liquid interfaces rather than on submerged surfaces. Three of the most potent biofilm-forming strains isolated from the dairy factory industrial samples, including Geobacillus thermoglucosidans, Geobacillus stearothermophilus, and Anoxybacillus flavithermus, have been characterized in detail with respect to their growth conditions and spore resistance. Strikingly, Geobacillus thermoglucosidans, which forms the most thermostable spores of these three species, is not able to grow in dairy intermediates as a pure culture but appears to be dependent for growth on other spoilage organisms present, probably as a result of their proteolytic activity. These results underscore the importance of abiotic and microbiotic factors in niche colonization in dairy factories, where the presence of thermophilic sporeformers can affect the quality of end products. © 2013,American Society for Microbiology.
- Published
- 2013
20. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4
- Subjects
Life ,PHS - Pharmacokinetics & Human Studies (tot 2013 daarna KFP) ,Biomedical Innovation ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Renal proximal tubule transporters can play a key role in excretion, pharmacokinetic interactions, and toxicity of immunosuppressant drugs. Basolateral organic anion transporters (OATs) and apical multidrug resistance-associated proteins (MRPs) contribute to the active tubular uptake and urinary efflux of these drugs, respectively. We studied the interaction of 12 immunosuppressants with OAT1- and OAT3-mediated [3H]-methotrexate (MTX) uptake in cells, and adenosine triphosphate-dependent [3H]-MTX transport in membrane vesicles isolated from human embryonic kidney 293 cells overexpressing human MRP2 and MRP4. Our results show that at a clinically relevant concentration of 10 μM, mycophenolic acid inhibited both OAT1- and OAT3-mediated [3H]-MTX uptake. Cytarabine, vinblastine, vincristine, hydrocortisone, and mitoxantrone inhibited only OAT1, whereas tacrolimus, azathioprine, dexamethasone, cyclosporine, and 6-mercaptopurine had no effect on both transporters. Cyclophosphamide stimulated OAT1, but did not affect OAT3. With regard to the apical efflux transporters, mycophenolic acid, cyclophosphamide, hydrocortisone, and tacrolimus inhibited MRP2 and MRP4, whereas mitoxantrone and dexamethasone stimulated [3H]-MTX transport by both transporters. Cyclosporine, vincristine, and vinblastine inhibited MRP2 only, whereas 6-mercaptopurine inhibited MRP4 transport activity only. Cytarabine and azathioprine had no effect on either transporter. In conclusion, we charted comprehensively the differences in inhibitory action of various immunosuppressive agents against the 4 key renal anion transporters, and we provide evidence that immunosuppressant drugs can modulate OAT1-, OAT3-, MRP2-, and MRP4-mediated transport of MTX to different extents. The data provide a better understanding of renal mechanisms underlying drug-drug interactions and nephrotoxicity concerning combination regimens with these compounds in the clinic. © 2013 Mosby, Inc. All rights reserved.
- Published
- 2013
21. Biological production of monoethanolamine by engineered Pseudomonas putida S12
- Subjects
Life ,Pseudomonas putida S12 ,food and beverages ,Biomedical Innovation ,FI - Functional Ingredients ,Monoethanolamine (MEA) ,Ethanolamine ammonia lyase (EAL) ,Environmental and Life Sciences ,Biology ,L-Serine decarboxylase (SDC) ,Healthy Living ,Amino acid decarboxylation ,EELS - Earth - Abstract
Pseudomonas putida S12 was engineered for the production of monoethanolamine (MEA) from glucose via the decarboxylation of the central metabolite l-serine, which is catalyzed by the enzyme l-serine decarboxylase (SDC).The host was first evaluated for its tolerance towards MEA as well as its endogenous ability to degrade this alkanolamine. Growth inhibition was observed at MEA concentrations above 100. mM, but growth was never completely arrested even at 750. mM of MEA. P. putida S12 was able to catabolize MEA in the absence of ammonia, but deletion of the eutBC genes that encode ethanolamine ammonia-lyase (EAL) enzyme sufficed to eliminate this capacity.For the biological production of MEA, the sdc genes from Arabidopsis thaliana (full-length and a truncated version) and Volvox carteri were expressed in P. putida S12. From 20mM of glucose, negligible amounts of MEA were produced by P. putida S12 δeutBC expressing the sdc genes from A. thaliana and V. carteri. However, 0.07mmol of MEA was obtained per g of cell dry weight of P. putida S12 δeutBC expressing the truncated variant of the A. thaliana SDC. When the medium was supplemented with l-serine (30mM), MEA production increased to 1.25mmolMEAg-1 CDW, demonstrating that l-serine availability was limiting MEA production. © 2013 Published by Elsevier B.V.
- Published
- 2013
22. Online Semi-Supervised Learning: Algorithm and Application in Metagenomics
- Subjects
MSB - Microbiology and Systems Biology ,Life ,Biomedical Innovation ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
As the amount of metagenomic data grows rapidly, online statistical learning algorithms are poised to play key rolein metagenome analysis tasks. Frequently, data are only partially labeled, namely dataset contains partial information about the problem of interest. This work presents an algorithm and a learning framework that is naturally suitable for the analysis of large scale, partially labeled metagenome datasets. We propose an online multi-output algorithm that learns by sequentially co-regularizing prediction functions on unlabeled data points and provides improved performance in comparison to several supervised methods. We evaluate predictive performance of the proposed methods on NIH Human Microbiome Project dataset. In particular we address the task of predicting relative abundance of Porphyromonas species in the oral cavity. In our empirical evaluation the proposed method outperforms several supervised regression techniques as well as leads to notable computational benefits when training the predictive model.
- Published
- 2013
23. The 1 MV multi-element AMS system for biomedical applications at the Netherlands Organization for Applied Scientific Research (TNO)
- Subjects
Life ,QS - Quality & Safety RAPID - Risk Analysis for Products in Development ,Biomedical Innovation ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
The Netherlands Organization for Applied Scientific Research (TNO) has installed a compact 1 MV multielement AMS system manufactured by High Voltage Engineering Europa B.V., The Netherlands. TNO performs clinical research programs for pharmaceutical and innovative foods industry to obtain early pharmacokinetic data and to provide anti-osteoporotic efficacy data of new treatments. The AMS system will analyze carbon, iodine and calcium samples for this purpose. The first measurements on blank samples indicate background levels in the low 10 -12 for calcium and iodine, making the system well suited for these biomedical applications. Carbon blanks have been measured at low 10 -16. For unattended, around-the-clock analysis, the system features the 200 sample version of the SO110 hybrid ion source and user friendly control software.
- Published
- 2013
24. Effects of chocolate supplementation on metabolic and cardiovascular parameters in ApoE3L mice fed a high-cholesterol atherogenic diet
- Subjects
Inflammation ,Life ,Renal inflammation ,Biomedical Innovation ,Liver injury ,Atherosclerosis ,Cardiovascular disease ,MHR - Metabolic Health Research ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Scope: Dietary intake of cocoa and/or chocolate has been suggested to exhibit protective cardiovascular effects although this is still controversial. The aim of this study was to investigate the effects of chocolate supplementation on metabolic and cardiovascular parameters. Methods and results: Four groups of ApoE*3Leiden mice were exposed to the following diet regimens. Group 1: cholesterol-free control diet (CO). Group 2: high-dose (1.0% w/w) control cholesterol (CC). Group 3: CC supplemented chocolate A (CCA) and Group 4: CC supplemented chocolate B (CCB). Both chocolates differed in polyphenol and fiber content, CCA had a relatively high-polyphenol and low-fiber content compared to CCB. Mice fed a high-cholesterol diet showed increased plasma-cholesterol and developed atherosclerosis. Both chocolate treatments, particularly CCA, further increased plasma-cholesterol and increased atherosclerotic plaque formation. Moreover, compared to mice fed a high-cholesterol diet, both chocolate-treated groups displayed increased liver injury. Mice on high-cholesterol diet had elevated plasma levels of sVCAM-1, sE-selectin and SAA, which was further increased in the CCB group. Similar effects were observed for renal inflammation markers. Conclusion: The two chocolate preparations showed unfavorable, but different effects on cardiometabolic health in E3L mice, which dissimilarities may be related to differences in chocolate composition. We conclude that discrepancies reported on the effects of chocolate on cardiometabolic health may at least partly be due to differences in chocolate composition. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
- Published
- 2013
25. Exploring the development of a decision support system (DSS) to prioritize engineered nanoparticles for risk assessment
- Subjects
Nanoparticle ,Risk management ,Life ,Characterisation ,Biomedical Innovation ,QS - Quality & Safety ,Toxicology ,Environmental and Life Sciences ,Biology ,Healthy Living ,Decision support system ,EELS - Earth ,Risk assessment - Abstract
Engineered nanoparticles (ENPs) have gained huge commercial interest because of their unique and size-related physicochemical properties. The diversity and complexity of ENPs is increasing with the introduction of next generation nanoparticles. The current approaches are not able to assess the safety of all types and applications of ENPs. Therefore, we are developing a decision support system (DSS) that helps to identify those ENPs and applications that should get priority in the risk assessment. This DSS smartly uses existing knowledge in publicly available databases. With the aid of vocabularies, knowledge rules and logic reasoning new knowledge will be derived. In this paper, the procedure for a DSS is described. Since this system is open by design, others can re-use and extend the DSS content, and newly developed DSS tools can be easily accommodated, which will make the DSS more effective over the years. Data of newly emerging studies will be used for the validation of the DSS. The results will benefit regulating authorities and scientists focussing on the development of inherently safe ENPs. © 2013 Springer Science+Business Media Dordrecht.
- Published
- 2013
26. A Clinical Evaluation of Statin Pleiotropy: Statins Selectively and Dose-Dependently Reduce Vascular Inflammation
- Subjects
Life ,Biomedical Innovation ,cardiovascular diseases ,MHR - Metabolic Health Research ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Statins are thought to reduce vascular inflammation through lipid independent mechanisms. Evaluation of such an effect in atherosclerotic disease is complicated by simultaneous effects on lipid metabolism. Abdominal aortic aneurysms (AAA) are part of the atherosclerotic spectrum of diseases. Unlike atherosclerotic occlusive disease, AAA is not lipid driven, thus allowing direct evaluation of putative anti-inflammatory effects. The anti-inflammatory potency of increasing doses (0, 20 or 40 mg/day) simvastatin or atorvastatin was evaluated in 63 patients that were at least 6 weeks on statin therapy and who underwent open AAA repair. A comprehensive analysis using immunohistochemistry, mRNA and protein analyses was applied on aortic wall samples collected during surgery. The effect of statins on AAA growth was analyzed in a separate prospective study in incorporating 142 patients. Both statins equally effectively and dose-dependently reduced aortic wall expression of NFκB regulated mediators (i.e. IL-6 (P
- Published
- 2013
27. Imaging of ultra-weak photon emission in a rheumatoid arthritis mouse model
- Subjects
MSB - Microbiology and Systems Biology ,Life ,Biomedical Innovation ,chemical and pharmacologic phenomena ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Ultra-weak photon emission (UPE) of a living system received scientific attention because of its potential for monitoring increased levels of reactive oxygen species (ROS) in the pathogenesis of rheumatoid arthritis (RA). In this study, a highly sensitive cryogenic charge-coupled device (CCD) camera was used to monitor in a RA mouse model the photon emission both without and with luminol. For that purpose, arthritis was induced in mice utilizing a repeated co-administration of type II collagen with lipopolysaccharide. Quantitative imaging of ultra-weak photon emission of the front and back paws of the animals was initiated 70 days after the first injection. All of the animals were measured once without luminol and once again immediately after luminol injection. Data illustrated a higher UPE intensity after initiating arthritis by CII-injection of the animals. The increase in UPE intensity was measured with and without using luminol indicating that this imaging technology may be useful for the future study of human RA. © 2013 van Wijk et al.
- Published
- 2013
28. The OSIRIS Weight of Evidence approach: ITS for the endpoints repeated-dose toxicity (RepDose ITS)
- Subjects
3R principle ,Alternative ,Biomedical Innovation ,Repeated-dose ,Weighting ,Environmental and Life Sciences ,Risk Assessment ,EELS - Earth ,Life ,Integrated Testing Strategy ,Non-testing method ,OSIRIS ,ITS ,QS - Quality & Safety ,Biology ,Healthy Living ,TTC - Abstract
In the FP6 European project OSIRIS, Integrated Testing Strategies (ITSs) for relevant toxicological endpoints were developed to avoid new animal testing and thus to reduce time and costs. The present paper describes the development of an ITS for repeated-dose toxicity called RepDose ITS which evaluates the conditions under which in vivo non-guideline studies are reliable. In a tiered approach three aspects of these "non-guideline" studies are assessed: the documentation of the study (reliability), the quality of the study design (adequacy) and the scope of examination (validity).The reliability is addressed by the method "Knock-out criteria", which consists of four essential criteria for repeated-dose toxicity studies. A second tool, termed QUANTOS (Quality Assessment of Non-guideline Toxicity Studies), evaluates and weights the adequacy of the study by using intra-criterion and inter-criteria weighting. Finally, the Coverage approach calculates a probability that the detected Lowest-Observed-Effect-Level (LOEL) is similar to the LOEL of a guideline study dependent on the examined targets and organs of the non-guideline study. If the validity and adequacy of the non-guideline study are insufficient for risk assessment, the ITS proposes to apply category approach or the Threshold of Toxicological Concern (TTC) concept, and only as a last resort new animal-testing. © 2013 Elsevier Inc.
- Published
- 2013
29. Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life
- Subjects
Mouse ,Biomedical Innovation ,Lactobacillus Rhamnosus ,macrophage ,Article ,Helper Cell ,EELS - Earth ,Immunomodulation ,Interleukin 10 ,Life ,Soluble Factors ,Controlled Study ,Tumor Necrosis Factor Alpha ,Biology ,In Vivo Study ,Prevention ,LGG ,Animal Experiment ,Newborn ,Nonhuman ,Environmental and Life Sciences ,Asthma ,Probiotic Agent ,Animal Cell ,In Vitro Study ,Cytokine Production ,female ,MSB - Microbiology and Systems Biology ,Allergic Airway Inflammation ,Healthy Living ,Neonatal Animal Model - Abstract
Background: Oral supplementation with probiotic bacteria can protect against the development of allergic and inflammatory diseases. Objective: The aim of this study was to investigate potential immunomodulatory and allergy-protective effects of processed Lactobacillus rhamnosus GG (LGG)-derived supernatants early in life in neonatal mice. Methods: In vitro, RAW264.7 mouse macrophages were stimulated with viable LGG, LGG-derived supernatants, prepared from different growth phases, and different size fractions thereof, and pro- and anti-inflammatory cytokine production was analysed. Supernatant fractions were also treated with protease, DNAse or carbohydrate-digesting enzymes to define the nature of immunomodulatory components. In vivo, neonatal Balb/c mice were orally supplemented with differentially processed LGG supernatants. Starting at 4 weeks of age, a protocol of ovalbumin-induced acute allergic airway inflammation was applied and protective effects of processed LGG supernatants were assessed. Results: Incubation of RAW264.7 cells with LGG-derived supernatants significantly increased TNFα and IL-10 production. These effects were not restricted to a particular molecular size fraction. Treatment with protease, but not with DNAse or carbohydrate-digesting enzymes, completely abolished the immunomodulatory activities. Incubation of TLR/NOD-transfected cells with LGG-derived supernatants revealed that recognition and signalling of bioactive components is mediated by TLR2 and NOD2. In vivo supplementation of newborn mice with processed LGG-derived supernatants resulted in pronounced protective effects on the allergic inflammatory response as reflected by reduced eosinophil numbers, modified T helper cell cytokine production, significantly less lung inflammation and reduced goblet cell numbers in comparison with sham-treated controls. Conclusion: LGG-derived supernatants exert immunomodulatory activities, and neonatal administration of specifically processed supernatants may provide an alternative to viable probiotics in reducing allergic inflammatory responses. © 2012 Blackwell Publishing Ltd.
- Published
- 2013
30. In-stream itaconic acid recovery from aspergillus terreus fedbatch fermentation
- Subjects
MSB - Microbiology and Systems Biology PID - Process & Instrumentation Development ,Biomedical Innovation ,Life Fluid Mechanics Chemistry & Energetics ,Biology ,Healthy Living ,EELS - Earth ,Environmental and Life Sciences TS - Technical Sciences - Abstract
The broad application of itaconic acid in synthetic resins, fibers, plastics, rubbers, surfactants, and oil additives has resulted in an increased demand for this product. As an end step of biobased itaconic acid production, a suitable downstream recovery procedure using Aspergillus terreus as a study model was analyzed. Here we present preliminary work to integrate fungal fermentation with in-stream product recovery (ISPR) using pertraction for itaconic acid. Based on prior knowledge and an initial solvent screening, solvent extraction using 2-methyl tetrahydrofuran (2m-THF) was selected as the preferred technique for recovering itaconic acid.1,2 © Copyright 2013, Mary Ann Liebert, Inc. 2013.
- Published
- 2013
31. Exploring host-microbiota interactions : New research approaches to improving metabolic and mental health
- Subjects
Environmental and Life Sciences ETP - Enabling Technology Programs ,Biomedical Innovation ,Life SB Systems Biology ,PHS - Pharmacokinetics & Human Studies ,Healthy Living ,Nutrition Health ,EELS - Earth - Abstract
The role of our intestinal microbiota reaches far beyond fermentation of indigestible food components. Apart from immunological functions, they have a major impact on our metabolic and perhaps even mental health. Dutch research organization TNO is exploring this exciting field, known as host-microbiota interactions, and is developing and integrating a range of advanced models, techniques and trials. The insights generated will support manufacturers in the development of functional foods targeted at, for example, obesity.
- Published
- 2013
32. The Göttingen minipig® as an alternative non-rodent species for immunogenicity testing: A demonstrator study using the IL-1 receptor antagonist anakinra
- Subjects
musculoskeletal diseases ,Anakinra ,QS - Quality & Safety TARA - Toxicology and Risk Assessment ,Anti-drug antibodies ,Biomedical Innovation ,Pharmacokinetics ,Life Triskelion BV ,Environmental and Life Sciences TNO Bedrijven ,Biology ,Immunogenicity ,Healthy Living ,Minipigs ,EELS - Earth - Abstract
The use of recombinant human proteins for the treatment of several diseases has increased considerably during the last decades. A major safety and efficacy issue of biopharmaceuticals is their potential immunogenicity. To prevent immunogenicity, biotechnology-derived proteins are engineered to be as human-like as possible. Immunogenicity is mainly determined in non-human primates (NHP), as they are considered to be the best predictive animal species for human safety, based on their close relatedness to man. As minipigs are increasingly used in the safety evaluation of (bio)pharmaceuticals, the predictive value of the minipig in immunogenicity testing was evaluated in this study, using anakinra as a model compound. Animals were treated subcutaneously with either placebo, low-(0.5mg/kg), or high-dose (5mg/kg) anakinra daily on 29 consecutive days. After the first and last dose, the pharmacokinetic (PK) profile of anakinra was evaluated. Antibodies directed to anakinra were measured on several time points during the treatment period. Furthermore, hematology, clinical chemistry, body weight, clinical signs, and histopathology of several organs were evaluated. No signs of toxicity were observed upon treatment with anakinra. PK parameters were comparable with those found in human and NHP studies performed with anakinra. All animals developed anti-anakinra antibodies. The results obtained in minipigs were comparable to those observed in monkeys. For anakinra, the predictive value of the minipig for immunogenicity testing was found to be comparable to that seen in NHP. However, more studies evaluating additional biopharmaceutical products are needed to support the use of the minipig as an alternative model for (immuno)toxicity testing, including immunogenicity. © 2013 Informa Healthcare USA, Inc.
- Published
- 2013
33. Exometabolomics Approaches in Studying the Application of Lignocellulosic Biomass as Fermentation Feedstock
- Subjects
inhibitor identification ,experimental design ,MSB - Microbiology and Systems Biology ,fermentation phenotypes ,Life ,Health ,food and beverages ,lignocellulosic biomass hydrolysates ,Biomedical Innovation ,exometabolomics approaches ,Environmental and Life Sciences ,Healthy Living ,EELS - Earth - Abstract
Lignocellulosic biomass is the future feedstock for the production of biofuel and bio-based chemicals. The pretreatment-hydrolysis product of biomass, so-called hydrolysate, contains not only fermentable sugars, but also compounds that inhibit its fermentability by microbes. To reduce the toxicity of hydrolysates as fermentation media, knowledge of the identity of inhibitors and their dynamics in hydrolysates need to be obtained. In the past decade, various studies have applied targeted metabolomics approaches to examine the composition of biomass hydrolysates. In these studies, analytical methods like HPLC, RP-HPLC, CE, GC-MS and LC-MS/MS were used to detect and quantify small carboxylic acids, furans and phenols. Through applying targeted metabolomics approaches, inhibitors were identified in hydrolysates and their dynamics in fermentation processes were monitored. However, to reveal the overall composition of different hydrolysates and to investigate its influence on hydrolysate fermentation performance, a non-targeted metabolomics study needs to be conducted. In this review, a non-targeted and generic metabolomics approach is introduced to explore inhibitor identification in biomass hydrolysates, and other similar metabolomics questions.
- Published
- 2013
34. Coordinated and Interactive Expression of Genes of Lipid Metabolism and Inflammation in Adipose Tissue and Liver during Metabolic Overload
- Subjects
MSB - Microbiology and Systems Biology ,Life ,food and beverages ,nutritional and metabolic diseases ,Biomedical Innovation ,lipids (amino acids, peptides, and proteins) ,Environmental and Life Sciences ,Biology ,Healthy Living ,hormones, hormone substitutes, and hormone antagonists ,EELS - Earth - Abstract
Background:Chronic metabolic overload results in lipid accumulation and subsequent inflammation in white adipose tissue (WAT), often accompanied by non-alcoholic fatty liver disease (NAFLD). In response to metabolic overload, the expression of genes involved in lipid metabolism and inflammatory processes is adapted. However, it still remains unknown how these adaptations in gene expression in expanding WAT and liver are orchestrated and whether they are interrelated.Methodology/Principal Findings:ApoE*3Leiden mice were fed HFD or chow for different periods up to 12 weeks. Gene expression in WAT and liver over time was evaluated by micro-array analysis. WAT hypertrophy and inflammation were analyzed histologically. Bayesian hierarchical cluster analysis of dynamic WAT gene expression identified groups of genes ('clusters') with comparable expression patterns over time. HFD evoked an immediate response of five clusters of 'lipid metabolism' genes in WAT, which did not further change thereafter. At a later time point (>6 weeks), inflammatory clusters were induced. Promoter analysis of clustered genes resulted in specific key regulators which may orchestrate the metabolic and inflammatory responses in WAT. Some master regulators played a dual role in control of metabolism and inflammation. When WAT inflammation developed (>6 weeks), genes of lipid metabolism and inflammation were also affected in corresponding livers. These hepatic gene expression changes and the underlying transcriptional responses in particular, were remarkably similar to those detected in WAT.Conclusion:In WAT, metabolic overload induced an immediate, stable response on clusters of lipid metabolism genes and induced inflammatory genes later in time. Both processes may be controlled and interlinked by specific transcriptional regulators. When WAT inflammation began, the hepatic response to HFD resembled that in WAT. In all, WAT and liver respond to metabolic overload by adaptations in expression of gene clusters that control lipid metabolism and inflammatory processes in an orchestrated and interrelated manner. © 2013 Liang et al.
- Published
- 2013
35. Monounsaturated and Saturated, but Not n-6 Polyunsaturated Fatty Acids Decrease Cartilage Destruction under Inflammatory Conditions: A Preliminary Study
- Subjects
Adult ,Linoleic acid ,Cell viability ,Enzyme release ,Prostaglandin E2 ,Cytotoxicity ,Collagenase 3 ,Saturated fatty acid ,Biomedical Innovation ,Limit of quantitation ,EELS - Earth ,Interstitial collagenase ,Cartilage degeneration ,Life ,Palmitic acid ,Fatty acids ,Human tissue ,Monounsaturated fatty acid ,Aged ,Immunoassay ,Inflammation ,Tumor necrosis factor alpha ,Disintegrin ,Lactate dehydrogenase ,Chondrocyte ,Lipid transport ,Environmental and Life Sciences ,Oleic acid ,Prostaglandin synthase ,Total knee replacement ,Cartilage ,Polyunsaturated fatty acid ,Glycosaminoglycan ,Cartilage cell ,Human cell ,Health ,Reverse transcription polymerase chain reaction ,Gene expression ,MHR - Metabolic Health Research ,Controlled study ,Healthy Living ,Glyceraldehyde 3 phosphate dehydrogenase ,Human - Abstract
Purpose: Osteoarthritis (OA) is associated with obesity in which altered fatty acid levels have been observed. We investigated whether the most common fatty acids in synovial fluid influence cartilage deterioration in OA. Design: Cartilage was obtained from OA patients undergoing total knee arthroplasty. Chondrocytes or cartilage explants were cultured with linoleic (n-6 polyunsaturated), oleic (monounsaturated), or palmitic (saturated) acid. After preculture, media were renewed and inflammation was simulated in half of the samples by addition of 10 ng/mL tumor necrosis factor-α (TNFα) with or without the fatty acids. Effects on lipid uptake (Oil-Red-O), cell toxicity (lactate dehydrogenase), prostaglandin-E2 (PGE2) release and gene expression for prostaglandin-endoperoxide synthase-2 (PTGS2), matrix metalloproteinase-1 (MMP1), and MMP13, and a disintegrin and metalloproteinase with thrombospondin motifs 4 were determined on chondrocytes in monolayer. Effects on glycosaminoglycan (GAG) release were evaluated on cartilage explants. Results: None of the fatty acids were cytotoxic and all were taken up by the cells, resulting in a higher amount of intracellular lipid in chondrocytes. Linoleic acid increased PGE2 production in the presence of TNFα. Oleic acid and palmitic acid inhibited MMP1 gene expression in chondrocytes stimulated with TNFα. In cartilage explants, GAG release was also inhibited by oleic acid and palmitic acid, and oleic acid decreased PTGS2 gene expression in stimulated chondrocytes. Conclusions: Linoleic acid has a pro-inflammatory effect on cartilage whereas oleic acid and palmitic acid seem to inhibit cartilage destruction. These results indicate that altered fatty acid levels may influence loss of cartilage structure in OA. © The Author(s) 2013.Chemicals/CAS: collagenase 3, 175449-82-8; glyceraldehyde 3 phosphate dehydrogenase, 9001-50-7; interstitial collagenase, 9001-12-1; lactate dehydrogenase, 9001-60-9; linoleic acid, 1509-85-9, 2197-37-7, 60-33-3, 822-17-3; oleic acid, 112-80-1, 115-06-0; palmitic acid, 57-10-3; prostaglandin E2, 363-24-6; prostaglandin synthase, 39391-18-9, 59763-19-8, 9055-65-6
- Published
- 2013
36. Liquid chromatography-tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cells
- Subjects
Plasma ,Life ,Validation ,Biomedical Innovation ,LC-MS/MS ,NAEs ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth ,Diet ,Endocannabinoids ,QS - Quality & Safety PHS - Pharmacokinetics & Human Studies - Abstract
The origin of N-acyl ethanolamides (NAEs) in plasma is not well understood, and it is possible that NAEs are present in plasma in esterified form. To test this hypothesis, a new and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of arachidonoyl ethanolamide, 2-arachidonoyl glycerol, docosahexaenoyl ethanolamide, dihomo-γ-linolenoyl ethanolamide, oleoyl ethanolamide, palmitoyl ethanolamide, and stearoyl ethanolamide in 100 μl of human plasma using a simple acetonitrile extraction step. Using this method, we determined (i) free and esterified NAE levels in human plasma, (ii) free and esterified NAE levels in plasma of mice fed with diets with different amounts of n-3 fatty acids, and (iii) esterified NAE levels in blood cells. Murine and human plasma extracts contained 20- to 60-fold higher levels of esterified NAEs than free NAEs. Moreover, the effect of dietary n-3 fatty acids on murine free plasma NAE profiles was similar for esterified NAEs. Finally, esterified NAEs were also present in murine blood cells, and their pattern followed the same diet effect as observed for free and esterified NAEs in plasma. Together, these data point to the presence of previously ignored pools of esterified NAEs in plasma and blood cells that correlated well with free NAE levels in plasma. © 2012 Elsevier Inc. All rights reserved.
- Published
- 2013
37. Reduced by-product formation and modified oxygen availability improve itaconic acid production in Aspergillus niger
- Subjects
Biomedical Innovation ,methodology ,Succinates ,itaconic acid ,Environmental and Life Sciences ,EELS - Earth ,Oxygen ,MSB - Microbiology and Systems Biology ,succinic acid derivative ,Life ,Aspergillus niger ,Biology ,metabolism ,Healthy Living ,Biotechnology - Abstract
Aspergillus niger has an extraordinary potential to produce organic acids as proven by its application in industrial citric acid production. Previously, it was shown that expression of the cis-aconitate decarboxylase gene (cadA) from Aspergillus terreus converted A. niger into an itaconic acid producer (Li et al., Fungal Genet Bio 48: 602-611, 2011). After some initial steps in production optimization in the previous research (Li et al., BMC biotechnol 12: 57, 2012), this research aims at modifying host strains and fermentation conditions to further improve itaconic acid production. Expression of two previously identified A. terreus genes encoding putative organic acid transporters (mttA, mfsA) increased itaconic acid production in an A. niger cis-aconitate decarboxylase expressing strain. Surprisingly, the production did not increase further when both transporters were expressed together. Meanwhile, oxalic acid was accumulated as a by-product in the culture of mfsA transformants. In order to further increase itaconic acid production and eliminate by-product formation, the non-acidifying strain D15#26 and the oxaloacetate acetylhydrolase (oahA) deletion strain AB 1.13 ΔoahA #76 have been analyzed for itaconic acid production. Whereas cadA expression in AB 1.13 ΔoahA #76 resulted in higher itaconic acid production than strain CAD 10.1, this was not the case in strain D15#26. As expected, oxalic acid production was eliminated in both strains. In a further attempt to increase itaconic acid levels, an improved basal citric acid-producing strain, N201, was used for cadA expression. A selected transformant (N201CAD) produced more itaconic acid than strain CAD 10.1, derived from A. niger strain AB1.13. Subsequently, we have focused on the influence of dissolved oxygen (D.O.) on itaconic acid production. Interestingly, reduced D.O. levels (10-25 %) increased itaconic acid production using strain N201 CAD. Similar results were obtained in strain AB 1.13 CAD + HBD2.5 (HBD 2.5) which overexpressed a fungal hemoglobin domain. Our results showed that overexpression of the hemoglobin domain increased itaconic acid production in A. niger at lower D.O. levels. Evidently, the lower levels of D.O. have a positive influence on itaconic acid production in A. niger strains.Chemicals/CAS: itaconic acid, 97-65-4; oxygen, 7782-44-7; Oxygen, 7782-44-7; Succinates; itaconic acid, 97-65-4
- Published
- 2013
38. Ex vivo systems to study host-microbiota interactions in the gastrointestinal tract
- Subjects
Mucosa ,Microcosms ,Life ,Biomedical Innovation ,Gut ,Microbiome ,Experimental model ,MSB - Microbiology and Systems Biology PHS - Pharmacokinetics & Human Studies ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
It is increasingly apparent that the microbial ecosystems in the mammalian gastrointestinal tract play an intricate role in health and disease. There is a growing interest in the development of targeted strategies for modulating health through the modification of these microbiota. Ecologists are faced with the challenge of understanding the structure and function of ecosystems, the component parts of which interact with each other in complex and diffuse ways. The human gut microbiota, with its high species richness and diversity (up to 1000 bacterial species per individual) including members of all three domains of life, situated in the dynamic environment of the gastrointestinal tract, is probably among the most complex ecosystems on this planet. In order to elucidate the mechanistic foundations, and physiological significance, of beneficial or pathogenic relationships between the gut microbiota and their hosts, researchers require tractable model ecosystems that allow to recapitulate and investigate host-microbe and microbe-microbe interactions. This review discusses ex vivo gastrointestinal models systems that can be used to gain mechanistic insights into the emergent properties of the host-microbial superorganism. © 2013 Elsevier Ltd. All rights reserved.
- Published
- 2013
39. The onset of type 2 diabetes: Proposal for a multi-scale model
- Subjects
Metaflammation ,Physical activity ,Biomedical Innovation ,Type 2 diabetes ,Environmental and Life Sciences ,EELS - Earth ,Computational biology ,Metabolism ,MSB - Microbiology and Systems Biology ,Life ,Data integration ,Multiscale modeling ,Biology ,Healthy Living ,Simulation - Abstract
Background: Type 2 diabetes mellitus (T2D) is a common age-related disease, and is a major health concern, particularly in developed countries where the population is aging, including Europe. The multi-scale immune system simulator for the onset of type 2 diabetes (MISSION-T2D) is a European Union-funded project that aims to develop and validate an integrated, multilevel, and patient-specific model, incorporating genetic, metabolic, and nutritional data for the simulation and prediction of metabolic and inflammatory processes in the onset and progression of T2D. The project will ultimately provide a tool for diagnosis and clinical decision making that can estimate the risk of developing T2D and predict its progression in response to possible therapies. Recent data showed that T2D and its complications, specifically in the heart, kidney, retina, and feet, should be considered a systemic disease that is sustained by a pervasive, metabolically-driven state of inflammation. Accordingly, there is an urgent need (1) to understand the complex mechanisms underpinning the onset of this disease, and (2) to identify early patient-specific diagnostic parameters and related inflammatory indicators. Objective: We aim to accomplish this mission by setting up a multi-scale model to study the systemic interactions of the biological mechanisms involved in response to a variety of nutritional and metabolic stimuli and stressors. Methods: Specifically, we will be studying the biological mechanisms of immunological/inflammatory processes, energy intake/expenditure ratio, and cell cycle rate. The overall architecture of the model will exploit an already established immune system simulator as well as several discrete and continuous mathematical methods for modeling of the processes critically involved in the onset and progression of T2D. We aim to validate the predictions of our models using actual biological and clinical data. Results: This study was initiated in March 2013 and is expected to be completed by February 2016. Conclusions: MISSION-T2D aims to pave the way for translating validated multilevel immune-metabolic models into the clinical setting of T2D. This approach will eventually generate predictive biomarkers for this disease from the integration of clinical data with metabolic, nutritional, immune/inflammatory, genetic, and gut microbiota profiles. Eventually, it should prove possible to translate these into cost-effective and mobile-based diagnostic tools. © Filippo Castiglione, Paolo Tieri, Albert De Graaf, Claudio Franceschi, Pietro Liò, Ben Van Ommen, Claudia Mazzà, Alexander Tuchel, Massimo Bernaschi, Clare Samson, Teresa Colombo, Gastone C Castellani, Miriam Capri, Paolo Garagnani, Stefano Salvioli, Viet Anh Nguyen, Ivana Bobeldijk-Pastorova, Shaji Krishnan, Aurelio Cappozzo, Massimo Sacchetti, Micaela Morettini, Marc Ernst.
- Published
- 2013
40. Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion
- Subjects
Bile acid sequestrant ,Life ,Nonesterified fatty acid ,Adipose tissue ,Hyperinsulinemic-euglycemic clamp ,Biomedical Innovation ,Insulin sensitivity ,MHR - Metabolic Health Research ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
Bile acid sequestrants (BASs) are cholesterollowering drugs that also affect hyperglycemia. The mechanism by which BASs exert these and other metabolic effects beyond cholesterol lowering remains poorly understood. The present study aimed to investigate the effects of a BAS, colestilan, on body weight, energy expenditure, and glucose and lipid metabolism and its mechanisms of action in high-fat-fed hyperlipidemic APOE*3 Leiden (E3L) transgenic mice. Mildly insulin-resistant E3L mice were fed a high-fat diet with or without 1.5% colestilan for 8 weeks. Colestilan treatment decreased body weight, visceral and subcutaneous fat, and plasma cholesterol and triglyceride levels but increased food intake. Blood glucose and plasma insulin levels were decreased, and hyperinsulinemic-euglycemic clamp analysis demonstrated improved insulin sensitivity, particularly in peripheral tissues. In addition, colestilan decreased energy expenditure and physical activity, whereas it increased the respiratory exchange ratio, indicating that colestilan induced carbohydrate catabolism. Moreover, kinetic analysis revealed that colestilan increased [ 3 H]NEFA incorporation in biliary cholesterol and phospholipids and increased fecal lipid excretion. Gene expression analysis in liver, fat, and muscle supported the above findings. In summary, colestilan decreases weight gain and improves peripheral insulin sensitivity in high-fat-fed E3L mice by enhanced NEFA incorporation in biliary lipids and increased fecal lipid excretion. Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc.
- Published
- 2013
41. Potential release scenarios for carbon nanotubes used in composites
- Subjects
Life ,Scenarios ,Release ,Carbon nanotubes ,Biomedical Innovation ,QS - Quality & Safety ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth ,Exposure - Abstract
The expected widespread use of carbon nanotube (CNT)-composites in consumer products calls for an assessment of the possible release and exposure to workers, consumers and the environment. Release of CNTs may occur at all steps in the life cycle of products, but to date only limited information is available about release of CNTs from actual products and articles. As a starting point for exposure assessment, exploring sources and pathways of release helps to identify relevant applications and situations where the environment and especially humans may encounter releases of CNTs. It is the aim of this review to identify various potential release scenarios for CNTs used in polymers and identify the greatest likelihood of release at the various stages throughout the life-cycle of the product. The available information on release of CNTs from products and articles is reviewed in a first part. In a second part nine relevant release scenarios are described in detail: injection molding, manufacturing, sports equipment, electronics, windmill blades, fuel system components, tires, textiles, incineration, and landfills. Release from products can potentially occur by two pathways; (a) where free CNTs are released directly, or more frequently (b) where the initial release is a particle with CNTs embedded in the matrix, potentially followed by the subsequent release of CNTs from the matrix. The potential for release during manufacturing exists for all scenarios, however, this is also the situation when exposure can be best controlled. For most of the other life cycle stages and their corresponding release scenarios, potential release of CNTs can be considered to be low, but it cannot be excluded totally. Direct release to the environment is also considered to be very low for most scenarios except for the use of CNTs in tires where significant abrasion during use and release into the environment would occur. Also the possible future use of CNTs in textiles could result in consumer exposure. A possibility for significant release also exists during recycling operations when the polymers containing CNTs are handled together with other polymers and mainly occupational users would be exposed. It can be concluded that in general, significant release of CNTs from products and articles is unlikely except in manufacturing and subsequent processing, tires, recycling, and potentially in textiles. However except for high energy machining processes, most likely the resulting exposure for these scenarios will be low and to a non-pristine form of CNTs. Actual exposure studies, which quantify the amount of material released should be conducted to provide further evidence for this conclusion. © 2013 The Authors.
- Published
- 2013
42. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake
- Subjects
Life ,Central nervous system ,digestive, oral, and skin physiology ,Biomedical Innovation ,Hyperphagia ,APOA5 ,MHR - Metabolic Health Research ,Environmental and Life Sciences ,Biology ,Triglyceride metabolism ,Healthy Living ,EELS - Earth - Abstract
Mutations in apolipoprotein A5 (APOA5) have been associated with hypertriglyceridemia in humans and mice. This has been attributed to a stimulating role for APOA5 in lipoprotein lipase-mediated triglyceride hydrolysis and hepatic clearance of lipoprotein remnant particles. However, because of the low APOA5 plasma abundance, we investigated an additional signaling role for APOA5 in high-fat diet (HFD)-induced obesity. Wild-type (WT) and Apoa5-/-mice fed a chow diet showed no difference in body weight or 24-h food intake (Apoa5-/-, 4.5±0.6 g; WT, 4.2±0.5 g), while Apoa5-/-mice fed an HFD ate more in 24 h (Apoa5-/-, 2.8±0.4 g; WT, 2.5±0.3 g, P
- Published
- 2013
43. Prediction of the origin of French Legionella pneumophila strains using a mixed-genome microarray
- Subjects
Micro-array ,Biomedical Innovation ,Environmental Exposure ,Pneumonia ,Environmental and Life Sciences ,Negative Predictive Value ,EELS - Earth ,Genomotyping ,Legionella Pneumophila ,MSB - Microbiology and Systems Biology ,Life ,Virulence-associated Epitope ,Random Forest Algorithm ,Public Health ,Legionnaires' Disease ,Biology ,Healthy Living - Abstract
Background: Legionella is a water and soil bacterium that can infect humans, causing a pneumonia known as Legionnaires' disease. The pneumonia is almost exclusively caused by the species L. pneumophila, of which serogroup 1 is responsible for 90% of patients. Within serogroup 1, large differences in prevalence in clinical isolates have been described. A recent study, using a Dutch Legionella strain collection, identified five virulence associated markers. In our study, we verify whether these five Dutch markers can predict the patient or environmental origin of a French Legionella strain collection. In addition, we identify new potential virulence markers and verify whether these can predict better. A total of 219 French patient isolates and environmental strains were compared using a mixed-genome micro-array. The micro-array data were analysed to identify predictive markers, using a Random Forest algorithm combined with a logistic regression model. The sequences of the identified markers were compared with eleven known Legionella genomes, using BlastN and BlastX; the functionality for each of the predictive markers was checked in the literature.Results: The five Dutch markers insufficiently predicted the patient or environmental origin of the French Legionella strains. Subsequent analyses identified four predictive markers for the French collection that were used for the logistic regression model. This model showed a negative predictive value of 91%. Three of the French markers differed from the Dutch markers, one showed considerable overlap and was found in one of the Legionella genomes (Lorraine strain). This marker encodes for a structural toxin protein RtxA, described for L. pneumophila as a factor involved in virulence and entry in both human cells and amoebae.Conclusions: The combination of a mixed-genome micro-array and statistical analysis using a Random Forest algorithm has identified virulence markers in a consistent way. The Lorraine strain and related Dutch and French Legionella strains contain a marker that encodes a RtxA protein which probably is involved in the increased prevalence in clinical isolates. The current set of predictive markers is insufficient to justify its use as a reliable test in the public health field in France. Our results suggest that genetic differences in Legionella strains exist between geographically distinct entities. It may be necessary to develop region-specific mixed-genome microarrays that are constantly adapted and updated. © 2013 Den Boer et al.; licensee BioMed Central Ltd.
- Published
- 2013
44. Profiling the biological activity of oxide nanomaterials with mechanistic models
- Subjects
Life ,Biomedical Innovation ,QS - Quality & Safety ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
In this study we present three mechanistic models for profiling the potential biological and toxicological effects of oxide nanomaterials. The models attempt to describe the reactivity, protein adsorption and membrane adhesion processes of a large range of oxide materials and are based on properties either calculated from experimental data or obtained by statistical regression methods. The information provided can be used to describe and predict the molecular initiating events that can lead to different toxicity and fate profiles of nanomaterials. It is suggested that this information be used collectively with in vitro models in a weight-of-evidence approach to hazard assessment. The theoretical framework underlying each model and its predictions are discussed in relation to experimental data. © 2013 IOP Publishing Ltd.
- Published
- 2013
45. Evaluation of symptom, clinical chemistry and metabolomics profiles during Rehmannia six formula (R6) treatment: An integrated and personalized data analysis approach
- Subjects
Liu Wei Di Huang Wan ,MSB - Microbiology and Systems Biology ,Nonlinear principal component analysis ,Life ,Diagnosis ,Rehmannia 6 formula ,Biomedical Innovation ,Systems biology ,Environmental and Life Sciences ,Biology ,Personalized medicine ,Healthy Living ,EELS - Earth - Abstract
Ethnopharmacological relevance Rehmannia Six Formula (R6, Chinese name is Liu Wei Di Huang Wan) is one of the most important classic Chinese medicine formula used to treat metabolic disorders related to aging. It was first reported in the Chinese medicine book titled 'Xiao Er Yao Zheng Zhi Jue by Qian Yi' (Chinese Song dynasty: 1035-1117). In modern times it is therefore often used to treat diabetes, pre-diabetes, fatigue and people with metabolic syndrome. The aim of this study is to measure changes in symptoms, clinical parameters and serum metabolite profiles during R6 treatment of human subjects with features of metabolic syndrome. Materials and methods Symptoms, clinical parameters and serum metabolites were measured before and after 4 and 8 weeks of R6 treatment. Nonlinear Principal Component Analysis was applied for the first time to conduct an integrated analysis of the three data sets. Correlation structures were compared before treatment and after 4 and 8 weeks of treatment. Additionally, a State Space Grid approach was used to study personalized changes in symptom profiles. Results The symptoms 'hectic fever' and 'spontaneous sweating' were found to be most relieved during R6 treatment. Most of the symptoms were less correlated with other variables after 8 weeks of R6 treatment. LDL-C, total cholesterol, systolic blood pressure and waist size were found to decrease during R6 treatment. Additionally, 10 of the 15 measured phosphatidylcholines were found to decrease. Personalized symptom profiles as described by Chinese medical terms show that most Yin deficiencies are addressed first by R6 treatment. However, in subjects with reduced or less Yin deficiency but which do have a substantial Qi deficiency a reduction of Qi deficiency is subsequently observed. Conclusions R6 treatment was shown to improve the lipid profile indicating a reduction of cardiovascular risk. Additionally, the changes observed in correlation structure indicate a different angle of looking at treatment effects. Less strong correlations between symptoms and metabolites suggest a healthier situation after R6 treatment. A State Space Grid analysis showed that the effect of R6 was different for the Yin deficiency subjects and the Qi deficiency subjects. The observed decrease of Yin deficiency related symptoms is in agreement with the use of R6 in Chinese medicine to nourish Yin. Observing individual differences in treatment effects is therefore an essential step in the development of personalized medicine. © 2013 Elsevier Ireland Ltd.
- Published
- 2013
46. Digestibility of transglutaminase cross-linked caseinate versus native caseinate in an in vitro multicompartmental model simulating young child and adult gastrointestinal conditions
- Subjects
Adults and children ,PHS - Pharmacokinetics & Human Studies (tot 2013 daarna KFP) QS - Quality & Safety ,Life ,Health ,Cross-linked caseinate ,Food matrix ,In vitro digestion ,Biomedical Innovation ,Environmental and Life Sciences ,Healthy Living ,EELS - Earth - Abstract
Aim of this study was to investigate the digestion of transglutaminase cross-linked caseinate (XLC) versus native caseinate (NC) in solution and in cheese spread under digestive conditions for adults and children mimicked in a gastrointestinal model. Samples were collected for gel electrophoresis and nitrogen analysis. The results showed no relevant differences between XLC and NC for total and α-amino nitrogen in digested fraction under adult and child conditions. However, the rate of digestion was depending on the food matrix. Gel electrophoresis showed the gastric breakdown of XLC without formation of pepsin resistant peptides larger than 4 kDa. NC was slowly digested in the stomach with formation of pepsin resistant fragments and was still detectable in the stomach after 90 min. In the small intestine the proteins were rapidly digested. XLC was digested to small peptides, while NC was resistant against pepsin digestion under gastric conditions of adults and children. © 2013 American Chemical Society.
- Published
- 2013
47. Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactionss
- Subjects
Life ,Biomedical Innovation ,PHS - Pharmacokinetics & Human Studies ,Environmental and Life Sciences ,Biology ,Healthy Living ,EELS - Earth - Abstract
In the 2012 Food and Drug Administration (FDA) draft guidance on drug-drug interactions (DDIs), a new molecular entity that inhibits Pglycoprotein (P-gp) may need a clinical DDI study with a P-gp substrate such as digoxin when themaximumconcentration of inhibitor at steady state divided by IC50 ([I1]/IC50) is0.1 or concentration of inhibitor based on highest approved dose dissolved in 250 ml divide by IC50 ([I2]/IC 50) is10. In this article, refined criteria are presented, determined by receiver operating characteristic analysis, using IC50 values generated by 23 laboratories. P-gp probe substrates were digoxin for polarized cell-lines and N-methyl quinidine or vinblastine for P-gp overexpressed vesicles. Inhibition of probe substrate transport was evaluated using 15 known P-gp inhibitors. Importantly, the criteria derived in this article take into account variability in IC50 values. Moreover, they are statistically derived based on the highest degree of accuracy in predicting true positive and true negative digoxin DDI results. The refined criteria of [I1]/IC50 0.03 and [I2]/IC50 45 and FDA criteria were applied to a test set of 101 in vitro-in vivo digoxin DDI pairs collated from the literature. The number of false negatives (none predicted but DDI observed) were similar, 10 and 12%, whereas the number of false positives (DDI predicted but not observed) substantially decreased from 51 to 40%, relative to the FDA criteria. On the basis of estimated overall variability in IC50 values, a theoretical 95%confidence interval calculation was developed for single laboratory IC 50 values, translating into a range of [I1]/IC50 and [I2]/IC50 values. The extent by which this range falls above the criteria is a measure of risk associated with the decision, attributable to variability in IC50 values. © 2013 by The American Society for Pharmacology.
- Published
- 2013
48. Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies
- Subjects
Inflammation ,QS - Quality & Safety TARA - Toxicology and Risk Assessment ,Fibrinogen ,Biomedical Innovation ,Rabbit ,Life Triskelion BV ,Environmental and Life Sciences TNO Bedrijven ,EELS - Earth ,C-reactive protein ,Safety/toxicity methods ,Biology ,Vaccine ,Healthy Living ,Adjuvant - Abstract
Introduction: Inflammatory reactions are one of the potential safety concerns that are evaluated in the framework of vaccine safety testing. In nonclinical studies, the assessment of the inflammation relies notably on the measurement of biomarkers. C-reactive protein (CRP) is an acute-phase plasma protein of hepatic origin that could be used for that purpose in toxicity studies with rabbits. Methods: To evaluate the utility of CRP as an additional inflammatory biomarker in adjuvant or vaccine toxicity studies, rabbits were injected on Day 0 with saline, aluminium phosphate, aluminium hydroxide, Adjuvant System (AS)01, AS03, AS15, or diphtheria-tetanus-whole cell pertussis-hepatitis B vaccine (DTPw-HB). Body weights, haematology parameters, CRP and fibrinogen levels were measured daily up to Day 7. Macroscopic changes at the injection site were also evaluated up to Day 7. At Day 7, a histopathological examination of the injection site was performed. Results: Like fibrinogen, CRP levels rapidly increased after the injection of Adjuvant Systems or DTPw-HB, peaking at Day 1, and returning to baseline in less than a week. The magnitude of the CRP increase was consistently higher than that of fibrinogen with a larger fold increase from background, providing a more sensitive evaluation. The number of circulating heterophils was also increased on Day 1 after the injection of Adjuvant Systems or DTPw-HB. The highest increases in CRP levels were observed after the injection of DTPw-HB or AS03, and were also associated with the persistence of mixed inflammatory cell infiltrates (including heterophils) at the injection sites on Day 7. No increases in CRP levels and in circulating heterophils were observed after injection of the aluminium salt adjuvants. Discussion: Our study supports the use of CRP as an accurate biomarker of acute inflammation in rabbits for vaccine toxicity studies and highlights an association between increased CRP levels and the recruitment of heterophils. © 2013 Elsevier Inc.
- Published
- 2013
49. T4 Report* Metabolomics in toxicology and preclinical research
- Subjects
Life ,Metabolomics ,Biomedical Innovation ,Preclinical Research ,QS - Quality & Safety ,Toxicology ,Environmental and Life Sciences ,Biology ,Healthy Living ,Regulatory Toxicology ,EELS - Earth - Abstract
Metabolomics, the comprehensive analysis of metabolites in a biological system, provides detailed information about the biochemical/physiological status of a biological system, and about the changes caused by chemicals. Metabolomics analysis is used in many fields, ranging from the analysis of the physiological status of genetically modified organisms in safety science to the evaluation of human health conditions. In toxicology, metabolomics is the -omics discipline that is most closely related to classical knowledge of disturbed biochemical pathways. It allows rapid identification of the potential targets of a hazardous compound. It can give information on target organs and often can help to improve our understanding regarding the mode-of-Action of a given compound. Such insights aid the discovery of biomarkers that either indicate pathophysiological conditions or help the monitoring of the efficacy of drug therapies. The first toxicological applications of metabolomics were for mechanistic research, but different ways to use the technology in a regulatory context are being explored. Ideally, further progress in that direction will position the metabolomics approach to address the challenges of toxicology of the 21st century. To address these issues, scientists from academia, industry, and regulatory bodies came together in a workshop to discuss the current status of applied metabolomics and its potential in the safety assessment of compounds. We report here on the conclusions of three working groups addressing questions regarding 1) metabolomics for in vitro studies 2) the appropriate use of metabolomics in systems toxicology, and 3) use of metabolomics in a regulatory context.
- Published
- 2013
50. Toward 6 log10 pulsed electric field inactivation with conductive plastic packaging material
- Subjects
Packaging films ,Pulsed electric field treatments ,Electric fields ,Packaging process ,Microorganisms ,Biomedical Innovation ,Preservative treatments ,Bacilli ,Packaging materials ,Investment costs ,EELS - Earth ,Life ,Plastic packaging materials ,Treatment time ,Investments ,Biology ,Pulsed electric field ,Electrically conductive plastics ,Plastic materials ,Inactivation models ,Environmental and Life Sciences ,Safety incidents ,Industrial research ,Electric field pulse ,Microbial inactivation ,MSB - Microbiology and Systems Biology ,Food grade ,Packaging ,Conductive plastics ,Specific energy ,Fruit juices ,Experiments ,Healthy Living ,Lactobacillus plantarum - Abstract
Generally, high grade products such as pulsed electric field (PEF) treated fruit juices are packaged after their preservative treatment. However, PEF treatment after packaging could avoid recontamination of the product and becomes feasible when electric field pulses of sufficient magnitude can be generated inside closed food containments. Microbial inactivation of 2 log10 was proved by using an electrically conductive plastic packaging material, and in this contribution it is shown that inactivation toward pasteurization level is achievable. Therefore, a series of microbial experiments with Lactobacillus plantarum at different energy levels were performed. The obtained microbial data with the plastic material have been compared with inactivation models from literature as well as with reference experiments. All treatments were done at ∼2.3 kV/mm, with treatment times between 10-600 μs, and the thermal load was below 38C. The maximum obtained microbial inactivation with the plastic packaging material was 5.9 log10 with a specific energy of 255 J/mL. PRACTICAL APPLICATIONS In order to further minimize the risk of contaminating microorganisms, e.g., introduced during the packaging process, this new technology of pulsed electric field (PEF) treatment after packaging can be beneficial in reducing food safety incidents. This technique also makes hygienic packaging machines superfluous, which will reduce operational and investment costs. By proving that PEF inactivation through a plastic packaging material is possible, the first step toward PEF treatment after packaging has been taken. Important next steps toward industrial realization are extensive research on food grade conductive packaging films, PEF in-pack processing methodologies and microbial investigation of different microorganisms. © 2011 Wiley Periodicals, Inc.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.